RecruitingNCT07029945
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
PHASE1 · PHASE2 · 152 planned enrolment
- Countries listed
- 2
- Registry update
- September 23, 2026
